Enveric Biosciences (ENVB) Short Interest Ratio & Short Volume $1.25 +0.01 (+0.40%) As of 07/3/2025 03:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Enveric Biosciences Short Interest DataEnveric Biosciences (ENVB) has a short interest of 228,400 shares, representing 10.67% of the float (the number of shares available for trading by the public). This marks a -25.02% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 776,104 shares to cover all short positions.Current Short Interest228,400 sharesPrevious Short Interest304,600 sharesChange Vs. Previous Month-25.02%Dollar Volume Sold Short$276.36 thousandShort Interest Ratio1.1 Days to CoverLast Record DateJune 15, 2025Outstanding Shares2,470,000 sharesFloat Size2,140,000 sharesShort Percent of Float10.67%Today's Trading Volume35,571 sharesAverage Trading Volume776,104 sharesToday's Volume Vs. Average5% Short Selling Enveric Biosciences? Sign up to receive the latest short interest report for Enveric Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENVB Short Interest Over TimeENVB Days to Cover Over TimeENVB Percentage of Float Shorted Over Time Enveric Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/2025228,400 shares $276.36 thousand -25.0%10.7%1.1 $1.21 5/31/2025304,600 shares $356.41 thousand +143.3%14.2%1.5 $1.17 5/15/2025125,200 shares $157.75 thousand -27.2%5.9%0 $1.26 4/30/2025172,000 shares $227.04 thousand -1.3%7.0%0.1 $1.32 4/15/2025174,200 shares $216.48 thousand -3.0%7.5%0.1 $1.24 3/31/2025179,500 shares $249.51 thousand -25.6%7.7%0.1 $1.39 3/15/2025241,100 shares $417.10 thousand -80.6%13.3%0.1 $1.73 2/28/20251,240,000 shares $3.47 million +351.4%77.5%0.5 $2.80 2/15/2025274,700 shares $439.52 thousand +17.8%15.2%0.1 $1.60 1/31/2025233,200 shares $487.39 thousand -42.8%16.9%1.5 $2.09 Get the Latest News and Ratings for ENVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/2025407,400 shares $145.44 thousand +498.2%4.3%0.8 $0.36 12/31/202468,100 shares $24.41 thousand -56.7%0.7%0.1 $0.36 12/15/2024157,200 shares $57.14 thousand +36.1%1.7%0.3 $0.36 11/30/2024115,500 shares $38.12 thousand -57.6%1.2%0.2 $0.33 11/15/2024272,200 shares $100.71 thousand -17.6%3.0%0.5 $0.37 10/31/2024330,200 shares $164.84 thousand +70.9%4.1%0.7 $0.50 10/15/2024193,200 shares $81.72 thousand -2.9%2.4%0.1 $0.42 9/30/2024199,000 shares $94.33 thousand -2.8%2.3%0.2 $0.47 9/15/2024204,700 shares $102.55 thousand -38.3%2.3%0.2 $0.50 8/31/2024332,000 shares $168.46 thousand -29.2%3.8%0.3 $0.51 8/15/2024469,100 shares $226.58 thousand -80.9%5.3%0.4 $0.48 7/31/20242,450,000 shares $1.15 million +1,760.3%31.2%1.7 $0.47 7/15/2024131,700 shares $71.38 thousand -13.4%1.7%0.2 $0.54 6/30/2024152,100 shares $95.25 thousand -43.4%2.0%0.3 $0.63 6/15/2024268,800 shares $198.91 thousand -20.5%3.5%0.5 $0.74 5/31/2024338,100 shares $263.72 thousand -50.2%4.5%0.2 $0.78 5/15/2024678,900 shares $534.97 thousand +736.1%8.9%0.1 $0.79 4/30/202481,200 shares $76.33 thousand -15.1%1.1%0 $0.94 4/15/202495,600 shares $88.10 thousand -62.5%1.4%0 $0.92 3/31/2024254,900 shares $254.90 thousand +69.5%4.2%0.1 $1.00 3/15/2024150,400 shares $162.43 thousand +58.2%3.2%0 $1.08 2/29/202495,100 shares $137.90 thousand +47.0%4.2%0 $1.45 2/15/202464,700 shares $54.28 thousand +181.3%2.5%0.2 $0.84 1/31/202423,000 shares $16.93 thousand -58.6%0.9%0.2 $0.74 1/15/202455,600 shares $71.17 thousand +334.4%2.3%1.4 $1.28 12/31/202312,800 shares $16.64 thousand +6.7%0.6%0.4 $1.30 12/15/202312,000 shares $16.08 thousand +263.6%0.6%0.7 $1.34 11/30/20233,300 shares $4.88 thousand -54.8%0.2%0.2 $1.48 11/15/20237,300 shares $10.40 thousand -62.4%0.4%0.4 $1.43 10/31/202319,400 shares $33.37 thousand -19.5%1.0%0.9 $1.72White House to reset Social Security? (Ad)Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. And it could have a major impact on how you collect Social Security - Click here to understand what' 10/15/202324,100 shares $50.85 thousand +121.1%1.3%0.3 $2.11 9/30/202310,900 shares $25.94 thousand -55.0%0.6%0.1 $2.38 9/15/202324,200 shares $55.18 thousand -45.3%1.2%0.3 $2.28 8/31/202344,200 shares $95.47 thousand -42.3%2.3%0.4 $2.16 8/15/202376,600 shares $182.31 thousand +86.4%4.0%0.1 $2.38 7/31/202341,100 shares $109.74 thousand +95.7%2.2%0 $2.67 7/15/202321,000 shares $60.27 thousand -43.1%1.1%0 $2.87 6/30/202336,900 shares $124.35 thousand -65.6%2.0%0 $3.37 6/15/2023107,400 shares $414.56 thousand -69.1%5.8%0 $3.86 5/31/2023347,300 shares $1.46 million +1,430.0%18.7%0.1 $4.19 5/15/202322,700 shares $34.05 thousand -30.2%1.2%0 $1.50 4/30/202332,500 shares $59.52 thousand +44.4%1.8%1 $1.83 4/15/202322,500 shares $34.20 thousand +39.8%1.2%0.6 $1.52 3/31/202316,100 shares $26.79 thousand +64.3%0.9%0.6 $1.66 3/15/20239,800 shares $16.95 thousand +71.9%0.6%0.3 $1.73 2/28/20235,700 shares $11.91 thousand -38.0%0.3%0.1 $2.09 2/15/20239,200 shares $24.93 thousand -37.8%0.5%0.2 $2.71 1/31/202314,800 shares $42.48 thousand -53.6%0.8%0.3 $2.87 1/15/202331,900 shares $90.28 thousand -21.2%1.7%0.7 $2.83 12/30/202240,500 shares $84.24 thousand -11.2%2.0%0.7 $2.08 12/15/202245,600 shares $97.58 thousand +27.4%2.3%0.9 $2.14 11/30/202235,800 shares $102.75 thousand -17.5%1.8%0.5 $2.87 11/15/202243,400 shares $147.56 thousand -37.7%2.2%0.4 $3.40 10/31/202269,700 shares $237.68 thousand +36.1%4.7%0.3 $3.41 10/15/202251,200 shares $175.10 thousand +55.2%3.6%0.1 $3.42 9/30/202233,000 shares $139.26 thousand -60.1%2.3%0.1 $4.22 9/15/202282,800 shares $477.76 thousand +11.7%5.8%0.2 $5.77 8/31/202274,100 shares $413.48 thousand -21.7%5.4%0.2 $5.58 8/15/202294,600 shares $624.36 thousand -43.4%6.9%0.2 $6.60 7/31/2022167,000 shares $1.07 million +158.5%16.7%0.6 $6.40 7/15/202264,600 shares $25.71 million +36.6%7.5%0.8 $398.00 6/30/20222,360,000 shares $505.75 thousand -23.9%N/A0.9 $0.21 6/15/20223,100,000 shares $651 thousand -4.6%N/A1.6 $0.21 5/31/20223,250,000 shares $642.53 thousand -2.1%N/A1.5 $0.20 5/15/20223,320,000 shares $664 thousand -2.4%N/A1.1 $0.20 4/30/20223,400,000 shares $918.34 thousand +165.6%N/A1 $0.27 4/15/20221,280,000 shares $384.38 thousand -19.5%N/A0.4 $0.30 3/31/20221,590,000 shares $524.70 thousand -17.6%N/A0.6 $0.33 3/15/20221,930,000 shares $536.54 thousand +498.1%N/A0.8 $0.28 2/28/2022322,700 shares $88.58 thousand -67.6%N/A0.1 $0.27 2/15/2022996,300 shares $313.83 thousand +421.9%N/A0.8 $0.32 1/31/2022190,900 shares $121.47 thousand -67.1%N/A0.3 $0.64 1/15/2022580,200 shares $434.45 thousand +143.0%N/A0 $0.75 12/31/2021238,800 shares $222.08 thousand -41.9%N/A0.3 $0.93 12/15/2021411,300 shares $435.98 thousand -50.8%N/A0.3 $1.06 11/30/2021835,400 shares $1.09 million -45.0%4.0%0.4 $1.30 11/15/20211,520,000 shares $2.74 million -22.5%7.3%0.4 $1.80 10/29/20211,960,000 shares $3.45 million +16.0%13.8%0.5 $1.76 10/15/20211,690,000 shares $3.19 million +33.1%10.9%0.5 $1.89 9/30/20211,270,000 shares $2.63 million -44.5%8.2%0.4 $2.07White House to reset Social Security? (Ad)Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. And it could have a major impact on how you collect Social Security - Click here to understand what' 9/15/20212,290,000 shares $6.07 million +178.1%14.2%0.7 $2.65 8/31/2021823,600 shares $1.64 million -5.0%5.1%0.3 $1.99 8/13/2021866,800 shares $1.49 million -9.4%5.4%0.7 $1.72 7/30/2021956,800 shares $1.83 million +8.2%5.9%0.7 $1.91 7/15/2021884,400 shares $1.82 million +17.3%5.5%0.6 $2.06 6/30/2021754,300 shares $1.80 million +37.8%4.7%0.5 $2.38 6/15/2021547,600 shares $1.21 million -48.3%3.4%0.3 $2.21 5/28/20211,060,000 shares $2.36 million +183.1%6.5%0.4 $2.23 5/14/2021374,400 shares $711.36 thousand -30.3%2.3%0.1 $1.90 4/30/2021536,900 shares $1.33 million -41.1%3.4%0.1 $2.48 4/15/2021911,800 shares $2.28 million +17.5%5.7%0.1 $2.50 3/31/2021776,000 shares $2.30 million +34.6%5.6%0.1 $2.97 3/15/2021576,400 shares $2.13 million +233.8%4.1%0.1 $3.70 2/26/2021172,700 shares $628.63 thousand -9.4%2.0%0.1 $3.64 2/12/2021190,700 shares $928.71 thousand +110.0%2.2%0.1 $4.87 1/29/202190,800 shares $345.95 thousand -42.4%10.0%0.1 $3.81 1/15/2021157,700 shares $657.61 thousand No Change17.4%0.2 $4.17 ENVB Short Interest - Frequently Asked Questions What is Enveric Biosciences' current short interest? Short interest is the volume of Enveric Biosciences shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 228,400 shares of ENVB short. 10.67% of Enveric Biosciences' shares are currently sold short. Learn More on Enveric Biosciences' current short interest. What is a good short interest ratio for Enveric Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENVB shares currently have a short interest ratio of 1.0. Learn More on Enveric Biosciences's short interest ratio. What is a good short interest percentage for Enveric Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.67% of Enveric Biosciences' floating shares are currently sold short. Is Enveric Biosciences' short interest increasing or decreasing? Enveric Biosciences saw a drop in short interest in the month of June. As of June 15th, there was short interest totaling 228,400 shares, a drop of 25.0% from the previous total of 304,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Enveric Biosciences' float size? Enveric Biosciences currently has issued a total of 2,470,000 shares. Some of Enveric Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Enveric Biosciences currently has a public float of 2,140,000 shares. How does Enveric Biosciences' short interest compare to its competitors? 10.67% of Enveric Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Enveric Biosciences: Minerva Neurosciences, Inc (0.58%), Eyenovia, Inc. (4.05%), AlloVir, Inc. (2.56%), Athira Pharma, Inc. (4.39%), Equillium, Inc. (11.89%), Citius Pharmaceuticals, Inc. (12.82%), Bright Green Co. (0.04%), Phio Pharmaceuticals Corp. (5.09%), BioCardia, Inc. (0.35%), Ainos, Inc. (36.64%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Enveric Biosciences stock? Short selling ENVB is an investing strategy that aims to generate trading profit from Enveric Biosciences as its price is falling. ENVB shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Enveric Biosciences? A short squeeze for Enveric Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENVB, which in turn drives the price of the stock up even further. How often is Enveric Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENVB, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Minerva Neurosciences Short Interest Eyenovia Short Interest AlloVir Short Interest Athira Pharma Short Interest Equillium Short Interest Citius Pharmaceuticals Short Interest Bright Green Short Interest Phio Pharmaceuticals Short Interest BioCardia Short Interest Ainos Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENVB) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enveric Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
